Filing Details
- Accession Number:
- 0001415889-25-002509
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-31 16:59:10
- Reporting Period:
- 2025-01-30
- Accepted Time:
- 2025-01-31 16:59:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613780 | Dbv Technologies S.a. | DBVT | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1760395 | Pharis Mohideen | C/O Dbv Technologies S.a. 107, Avenue De La Republique Chatillon I0 92320 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2025-01-30 | 600 | $0.85 | 110,510 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The ordinary shares may be represented by American Depositary Shares, each of which currently represents one ordinary share.
- Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
- This sales price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0419 to EURO 1.00 as of January 30, 2025.